Senior insider sale
CHIEF EXECUTIVE OFFICER at WHITEHAWK THERAPEUTICS, INC. — senior position signals high conviction
$1.05M
302.52K shares
What this filing means
LENNON DAVID JAMES plans to sell 302.52K shares of WHITEHAWK THERAPEUTICS, INC. valued at approximately $1.05M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/2/2026ACC: 0001995275-26-000005
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Mar 2026
302.52K
Shares to sell
$1.05M
Approx. market value
775.83K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
4/1/2026
775.83KTotal acquired775.83K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/1/2026 | Restricted Stock Units N/A | 775.83K | — |
| Total | 775.83K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
5.10K
Market value
$16.9K
3/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
297.42K
Market value
$1.03M
4/2/2026
Total
Units
302.52K
Value
$1.05M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/2/2026 | 5.10K | $16.9K | — | Completed |
| Planned — Approximate Date | ||||
4/2/2026 | 297.42K | $1.03M | NASDAQ | Planned |
| Total | 302.52K | $1.05M | ||